News

Clee Medical honored with the W.A De Vigier award 2025, one of Switzlerand’s most prestigious prizes for entrepreneurs and start ups. 🎉

This recognition fuels our mission to enable safer, more precise access to the brain by combining novel real-time ultra-high-resolution imaging with AI-guided navigation to treat neurological conditions ranging from neurostimulation, epilepsy, cancer, and beyond.

This milestone wouldn’t have been possible without the incredible support from our partners, advisors,...

Clee Medical Advances to the Next Stage of the W.A. de Vigier Award 2025 🎉

We are excited to share that Clee Medical has been selected as one of the 15 startups advancing to the next stage of the prestigious W.A. de Vigier Award 2025!

The W.A. de Vigier Award is Switzerland’s longest-standing prize for young entrepreneurs, recognizing innovative startups that have the potential to make a significant impact in...

Clee Medical Wins Future of Health Grant 2025 🎉

We are thrilled to announce that Clee Medical has been selected as one of the six startups to receive the prestigious Future of Health Grant 2025 amonst 243 applicants!

The Future of Health Grant, initiated by CSS and EPFL Innovation Park, recognizes and supports groundbreaking startups that are shaping the future of healthcare. This recognition is a testament to our commitment...

Exciting Milestone: Our First Scientific Paper Published in Biomedical Optics Express!

We are thrilled to announce the publication of our first scientific technical paper, “Minimally-invasive common-path OCT system for neurosurgery applications” in Biomedical Optics Express. This marks a significant milestone for our team at Clee Medical as we advance the frontiers of neurosurgical imaging technology.

Our research presents a groundbreaking optical coherence tomography (OCT) system tailored specifically for neurosurgery. This minimally...

Real-Time Precision: Overcoming the Limitations of MRI in Neurosurgery

In stereotactic neurosurgery, procedures such as neuromodulation, biopsies, stereoelectroencephalography (sEEG), and lesioning demand sub-millimeter precision to achieve their intended therapeutic effect. However, current imaging methods—most commonly MRI (Magnetic Resonance Imaging)—pose significant limitations that impact surgical accuracy and outcomes. At Clee Medical, we have developed an intraoperative imaging system designed to overcome these challenges, enabling real-time neural targeting with micron-level precision.

The...

Clee Medical, a neuro technology start up focused on transforming the landscape of brain treatments. Officially incorporated in October 2024, Clee Medical is proud to spin out of the Wyss Center in Geneva, Switzerland. With a vision to revolutionize neurointerventional precision and outcomes, Clee Medical is at the forefront of developing cutting-edge, minimally invasive neurotechnologies that empower clinicians with real-time imaging, AI-driven navigation, and machine learning insights for true confidence in neural targeting. Clee Medical’s...